Feyerabend, Susan
Saad, Fred
Perualila, Nolen Joy http://orcid.org/0000-0001-8402-0399
Van Sanden, Suzy
Diels, Joris
Ito, Tetsuro
De Porre, Peter
Fizazi, Karim
Funding for this research was provided by:
Janssen Pharmaceutica NV
Article History
First Online: 21 November 2019
Compliance with Ethical Standards
:
: This study was funded by Janssen Pharmaceutica NV.
: S Feyerabend has nothing to disclose. F. Saad reports grants, personal fees, and non-financial support from Janssen and Sanofi related to the conduct of the study, and grants, personal fees, and non-financial support from Astellas and Bayer unrelated to the submitted work. N.J. Perualila, S. Van Sanden, J. Diels, T. Ito, and P. De Porre are employees of Janssen. S. Van Sanden, T. Ito, and P. De Porre are shareholders of Janssen’s parent company, Johnson & Johnson. K. Fizazi reports financial support for participation in advisory boards for Amgen, AstraZeneca, Astellas, Bayer, Janssen, Sanofi, Orion, and CureVac.
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the local Institutional Review Boards for each site and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
: Informed consent was obtained from all individual participants included in the LATITUDE study (ClinicalTrials.gov identifier NCT01715285).